Wegovy vs Zepbound: Which One Costs Less Per Pound in 2026?
Quick Answer
Zepbound wins on raw value: it lists $289/month cheaper ($1,060 vs $1,349) and drops more weight (20-22% vs 15-17%), so each pound costs you far less.The wildcard is Wegovy's $149/month oral pill — the lowest sticker price of any branded GLP-1 here. From July 2026, both land at $50/month on Medicare, which flattens the gap entirely. Either way you're choosing an FDA-approved weight drug.
| Feature | Wegovy | Zepbound |
|---|---|---|
| Active Ingredient | Semaglutide | Tirzepatide |
| Manufacturer | Novo Nordisk | Eli Lilly |
| Mechanism | GLP-1 receptor agonist | Dual GLP-1/GIP receptor agonist |
| FDA Approved For | Weight management + CV risk | Chronic weight management |
| Avg Weight Loss | 15-17% body weight | 20-22% body weight |
| Monthly Price | $1,349 | $1,060 |
| Oral Option | Yes ($149/mo pill) | No |
| Medicare (Jul 2026) | Yes — $50/month | Yes — $50/month |
| Doses | 0.25mg to 2.4mg weekly | 2.5mg to 15mg weekly |
| Year Approved | 2021 | 2023 |
- Wegovy
- Semaglutide
- Zepbound
- Tirzepatide
- Wegovy
- Novo Nordisk
- Zepbound
- Eli Lilly
- Wegovy
- GLP-1 receptor agonist
- Zepbound
- Dual GLP-1/GIP receptor agonist
- Wegovy
- Weight management + CV risk
- Zepbound
- Chronic weight management
- Wegovy
- 15-17% body weight
- Zepbound
- 20-22% body weight
- Wegovy
- $1,349
- Zepbound
- $1,060
- Wegovy
- Yes ($149/mo pill)
- Zepbound
- No
- Wegovy
- Yes — $50/month
- Zepbound
- Yes — $50/month
- Wegovy
- 0.25mg to 2.4mg weekly
- Zepbound
- 2.5mg to 15mg weekly
- Wegovy
- 2021
- Zepbound
- 2023
Cost Per Pound Lost: The Number That Actually Matters
Sticker price alone misleads you, because the two drugs don't deliver the same result. The honest metric is dollars spent per pound dropped. Take a 240-pound person on the top dose for a year: Zepbound's 20-22% averages out to roughly 48-52 pounds lost, against Wegovy's 15-17%, or about 35-40 pounds.
Run the math on list price and Zepbound is the value play twice over — it's $289 a month cheaperand it moves the scale further. That combination is why, before any insurance or coupon enters the picture, Zepbound ends up costing meaningfully less per pound. The edge traces back to tirzepatide's dual GLP-1/GIP action, which hits appetite and metabolism on two fronts instead of one.
Cost Without Insurance vs the Discount Routes
Paying cash, you're looking at $1,060/month for Zepbound and $1,349/month for Wegovyat full list. But almost nobody should pay full list. Wegovy's oral pill (live since January 2026) lands at just $149/month, the single cheapest branded option on this page. Manufacturer savings cards and telehealth bundles trim the injectables further, and from July 1, 2026 both drop to $50/month on Medicare — at which point sticker price stops mattering and tolerability and results take over.
Do You Pay More in Side Effects?
There's no "cheaper" drug here on tolerability — the GI profiles run almost identical: nausea (up to 44%), diarrhea (30%), vomiting (24%), and constipation (24%). Most of it fades within 4-8 weeks as your dose climbs. Neither one buys you a smoother ride, so don't let side-effect fear, rather than price and results, drive the decision.
Which Is the Smarter Buy for You?
Wegovy Is the Better Buy If:
- + The $149/month oral pill fits your budget best
- + You want to skip needles entirely
- + You have heart-risk factors it's approved to address
- + A longer real-world track record reassures you
Zepbound Is the Better Buy If:
- + You want the lowest cost per pound lost
- + The lower $1,060 list price wins for you
- + A weekly injection doesn't bother you
- + You want the strongest dual-mechanism results
Find the Lowest Price on Either Drug
See which telehealth providers quote the best monthly price on Wegovy and Zepbound right now.
See Provider Rankings